CIPLA
Back to Income Statement
|
CIPLA Last 5 Year Appropriations History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Appropriations | ₹26,711 Cr | ₹22,179 Cr | ₹18,471 Cr | ₹16,054 Cr | ₹13,523 Cr |
What is the latest Appropriations of CIPLA ?
| Year | Appropriations |
|---|---|
| Mar2026 | ₹26,711 Cr |
| Mar2025 | ₹22,179 Cr |
| Mar2024 | ₹18,471 Cr |
| Mar2023 | ₹16,054 Cr |
| Mar2022 | ₹13,523 Cr |
How is Appropriations of CIPLA Trending?
| Years | Appropriations | % Change | |
|---|---|---|---|
| Mar2026 | ₹26,711 Cr | 20.44 | |
| Mar2025 | ₹22,179 Cr | 20.07 | |
| Mar2024 | ₹18,471 Cr | 15.06 | |
| Mar2023 | ₹16,054 Cr | 18.72 | |
| Mar2022 | ₹13,523 Cr | - | |
Compare Appropriations of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹114,313.8 Cr | 1.5% | 6.4% | -7.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,299.0 Cr | 1% | 7.5% | 7.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹297,325.0 Cr | 0.8% | 22.8% | 71.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹178,727.0 Cr | 0.2% | 1.9% | 20.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,145.0 Cr | 0.8% | 12.2% | 12.3% | Stock Analytics | |
| MANKIND PHARMA | ₹109,880.0 Cr | 1.3% | 16.8% | 17.2% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 1.5% |
6.4% |
-7.8% |
| SENSEX | 2.9% |
13.9% |
-0.8% |
You may also like the below Video Courses